CytoTools AG - Product Pipeline Review - Q4 2010

GlobalData, November 2010, Pages: 27

CytoTools AG – Product Pipeline Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “CytoTools AG - Product Pipeline Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- CytoTools AG - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of CytoTools AG human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of CytoTools AG with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the CytoTools AG’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate CytoTools AG’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of CytoTools AG in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the CytoTools AG’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with CytoTools AG.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of CytoTools AG and identify potential opportunities in those areas.

List of Tables
List of Figures
CytoTools AG Snapshot
CytoTools AG Overview
Key Information
Key Facts
CytoTools AG – Research and Development Overview
Key Therapeutic Areas
CytoTools AG – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
CytoTools AG – Pipeline Products Glance
CytoTools AG Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
CytoTools AG–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
CytoTools AG – Drug Profiles
CI 05
Product Description
Mechanism of Action
R&D Progress
Pep 04
Product Description
Mechanism of Action
R&D Progress
HMW 02Ap
Product Description
Mechanism of Action
R&D Progress
HMW 02Ak
Product Description
Mechanism of Action
R&D Progress
LMW 0x
Product Description
Mechanism of Action
R&D Progress
CytoTools AG – Pipeline Analysis
CytoTools AG – Pipeline Products by Therapeutic Class
CytoTools AG – Pipeline Products by Route of Administration
CytoTools AG – Pipeline Products by Molecule Type
CytoTools AG – Locations And Subsidiaries
Head Office
Financial Deals Landscape
CytoTools AG, Deals Summary, 2004 to 2010
CytoTools AG Detailed Deal Summary
Equity Offering
CytoTools Completes Private Placement Of $3 Million
Licensing Agreements
CytoTools Enters Into Licensing Agreement With CENTAUR Pharmaceuticals
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Customers who bought this item also bought

• eLEARNING - Global Strategic Business Report
• Sports and Fitness Nutrition - Global Strategic Business Report
• Aerospace and Defense Industry - Global Strategic Business Report
• Charter Schools - Global Outlook
• Commercial And Military Flight Simulation - Global Strategic Business Report
• Biodefense Industry - Market to Benefit from Federal Funding such as the BIO EDEP Fund to Support Security Plans
• Education Services - Global Strategic Business Report
• Aerospace and Defense Industry - Global Outlook
• Aerospace and Defence Industry - Global Strategic Business Report
• Global Defense Vehicle Industry 2012-2017: Trend, Profit, and Forecast Analysis